Pharmacy Abroad 2026: GPhC UK, AHPRA Australia MLTSSL, PEBC Canada — Indian PharmD and BPharm Graduate Guide
By AnyUni Team · Updated 2 November 2026
Pharmacy is a globally regulated profession with clear registration pathways that Indian BPharm and PharmD graduates can follow to practice internationally. Australia's Pharmacist (ANZSCO 251511) is on the MLTSSL — eligible for 189 Skilled Independent PR. The UK faces a pharmacy workforce shortage driving GPhC (General Pharmaceutical Council) reforms to expedite international registration. Canada's PEBC (Pharmacy Examining Board of Canada) administers qualifying exams accessible to internationally educated pharmacists. USA's NAPLEX (licensure exam) is available from India through Prometric. Indian pharmacy graduates — particularly PharmD holders from PCI-approved institutions — are well-positioned for these pathways, yet competitors rarely document the specific registration exam details, INR costs, or subject-specific recognition that these graduates need.
Australia — ANZSCO 251511 Pharmacist MLTSSL and AHPRA Registration
Pharmacist ANZSCO 251511 — MLTSSL Status:
Australian Pharmacist (ANZSCO 251511) is on Australia's MLTSSL — eligible for 189 Skilled Independent PR visa without employer or state sponsor.
Skills Assessment Body:
Australian Pharmacy Council (APC) — conducts skills assessment for internationally qualified pharmacists
- Stage 1: Document Assessment
- Stage 2: APC Bridging Programme (if not substantially equivalent)
- Stage 3: AHPRA Registration
- PharmD (6-year programme from PCI-approved institution): APC generally assesses as substantially equivalent for document stage
- BPharm (4-year): assessed case by case; bridging may be required
- Indian PharmD curriculum includes hospital pharmacy rotations, clinical clerkships — these match Australian competency expectations well
- Verify your institution's PCI approval at pci.nic.in
- JSS College of Pharmacy (Mysore and Ooty — both campuses)
- Manipal College of Pharmaceutical Sciences
- PSG College of Pharmacy
- Amrita School of Pharmacy
- Bombay College of Pharmacy
- Delhi Pharmaceutical Sciences and Research University
- SRM College of Pharmacy
- Community Pharmacist (entry): AUD 55,000–75,000 (≈₹31.1–42.5 lakh)
- Hospital Pharmacist (entry): AUD 70,000–90,000 (≈₹39.6–51.0 lakh)
- Clinical Pharmacist (3–5yr): AUD 85,000–115,000 (≈₹48.1–65.1 lakh)
- Pharmacist-in-Charge (community): AUD 90,000–130,000 (≈₹51.0–73.6 lakh)
- Hospital Pharmacy Manager: AUD 110,000–160,000 (≈₹62.3–90.6 lakh)
- Consultant Pharmacist (aged care, medication management review): AUD 100,000–160,000 (≈₹56.6–90.6 lakh)
- Pharmacist FIFO (mining site pharmacy): AUD 120,000–180,000 package (≈₹68–1,01.9 lakh)
- ANZSCO 251511 on MLTSSL → 189 available
- Typical points profile: Age (25–32yr: 30pts), English (Superior/IELTS 8: 20pts), Overseas experience (5–8yr: 10pts), PharmD (15pts), Australian study (5pts) → Total ~80 pts
- Current 189 pharmacy invitations: typically issued to 75+ points profiles
- 190 State nomination: Victoria, NSW, QLD — pharmacy listed on state SOL lists — lower points needed with nomination
UK — GPhC Registration, OSPAP, and UK Pharmacy Careers
GPhC (General Pharmaceutical Council) — UK Pharmacy Regulator:
To practise as a pharmacist in UK, registration with GPhC is mandatory.
Route for Internationally Educated Pharmacists:
GPhC's recognition of overseas pharmacists underwent reform in 2024. The current pathway for Indian PharmD/BPharm graduates:
- GPhC assesses whether Indian pharmacy qualification is equivalent to UK MPharm (4-year integrated Masters)
- Application fee: £370 = ₹39,500 (2025)
- Submission: transcript, PharmD certificate, evidence of licensure from PCI/State Pharmacy Council
- UK MPharm standard: GPhC Standards for the Initial Education and Training of Pharmacists
- 1-year postgraduate conversion programme at a UK School of Pharmacy
- Designed specifically for overseas-qualified pharmacists
- Universities offering OSPAP: University of Sunderland, Robert Gordon University (Aberdeen), University of Portsmouth, Keele University, Aston University
- OSPAP cost: £10,000–13,000/yr (≈₹1,06,800–1,38,800)
- The programme covers: UK pharmacy law, ethics, clinical pharmacy, and patient safety
- Completion → eligible to sit GPhC registration assessment examinations
- Two-part exam: Calculations paper + Clinical skills paper
- Exam fees: £540 = ₹57,700 (each attempt)
- Pass rate (UK MPharm graduates): ~70%; OSPAP graduates: similar
- Can be taken in UK test centres
- 12 months supervised practice in UK pharmacy (community or hospital)
- Employer-arranged; paid role (£20,000–26,000/yr during pre-reg = ₹21.4–27.8 lakh)
- Annual registration fee: £268 = ₹28,600
- Registered Pharmacist = can practise independently in UK
New 2026 GPhC Pathway Reform:
GPhC is piloting direct assessment pathways (without OSPAP) for experienced international pharmacists with 3+ years post-qualification experience — check gphc.org.uk for current guidance as this pathway is evolving in 2026.
- Community Pharmacist (pre-reg): £20,000–26,000 (≈₹21.4–27.8 lakh)
- Newly Qualified Pharmacist (Band 6 NHS): £35,392–42,618 (≈₹37.8–45.5 lakh)
- Clinical Pharmacist (Band 7 NHS): £43,742–50,056 (≈₹46.7–53.4 lakh)
- Specialist/Advanced Pharmacist (Band 8a NHS): £53,755–60,504 (≈₹57.4–64.6 lakh)
- Principal/Consultant Pharmacist (Band 8b-c): £60,000–100,000+ (≈₹64.1–1,06.8 lakh)
- Community Pharmacy Superintendent (chain pharmacy): £50,000–100,000 (≈₹53.4–1,06.8 lakh)
- Band 6: Newly qualified pharmacist, clinical pharmacy
- Band 7: Senior clinical pharmacist, specialty roles (oncology, critical care, HIV)
- Band 8a–8c: Advanced/principal/consultant pharmacist, pharmacy managers
- Clinical Pharmacist roles in NHS are sponsored for Skilled Worker visa
UK Shortage Context:
UK has 3,000+ pharmacy vacancies nationally. NHS trusts actively sponsor international pharmacists, particularly for hospital clinical pharmacy. Locum pharmacist rates: £25–35/hr in community (≈₹2,670–3,740/hr)
IELTS for GPhC:
GPhC English requirement: IELTS 7.0 overall, 6.5 in each component (specific to pharmacy)
Canada — PEBC Qualifying Exams and Provincial Licensure
PEBC (Pharmacy Examining Board of Canada):
PEBC administers the national qualifying examinations for internationally educated pharmacists. Provincial licensing follows PEBC success.
PEBC Process for Indian Pharmacists:
- First exam: determines if Indian pharmacy qualification is equivalent to Canadian BScPharm/PharmD standard
- Fee: CAD 775 = ₹47,200
- Format: 200 MCQ over 4.25 hours
- Taken at: Pearson VUE test centres — available in India (Mumbai, Delhi, Bangalore, Hyderabad, Pune, Chennai, Kolkata test centres)
- Topics: pharmaceutics, pharmacology, biopharmaceutics, pharmacokinetics, pharmacy practice, pharmacy law (Canadian context important — study guide available)
- Pass rate for internationally educated pharmacists: ~55–65%
- QE Part 1 (MCQ): CAD 650 = ₹39,600 — knowledge-based exam
- QE Part 2 (OSCE): CAD 1,175 = ₹71,600 — Objective Structured Clinical Examination; Canada only
- Ontario College of Pharmacists (OCP): CAD 950 = ₹57,900 licence
- Alberta College of Pharmacy (ACP): CAD 675 = ₹41,100
- BC College of Pharmacists (BCCOP): CAD 525 = ₹31,900
- Pharmacist Licence (provincial): allows independent practice in that province
- Pharmacist: NOC 31120 (TEER 1) — Federal Skilled Worker eligible
- CEC: After 1 year Canadian pharmacy experience → PR
- Pharmacist listed on multiple provincial PNP streams as in-demand occupation
- Community Pharmacist (entry): CAD 55,000–80,000 (≈₹33.5–48.7 lakh)
- Hospital Clinical Pharmacist: CAD 80,000–110,000 (≈₹48.7–67.0 lakh)
- Pharmacist-in-Charge (chain): CAD 90,000–130,000 (≈₹54.8–79.1 lakh)
- Director of Pharmacy (hospital): CAD 110,000–180,000 (≈₹67.0–1,09.6 lakh)
PEBC EE Available from India:
The key advantage for Indian candidates is that PEBC Evaluating Examination (Step 1) is available at Pearson VUE centres across India. Candidates can pass EE while still in India, then apply for Canadian study/work visa. This reduces the cost and risk of the Canadian pathway significantly — only QE Part 2 OSCE requires travel to Canada.
USA — NAPLEX, MPJE, and State Licensure for Indian Pharmacists
- NAPLEX (North American Pharmacist Licensure Examination): competency exam
- MPJE (Multistate Pharmacy Jurisprudence Examination): law exam
- State Board licensure in each state they practise in
- FPGEE (Foreign Pharmacy Graduate Equivalency Examination): USD 550 = ₹45,980
- English language certification: TOEFL iBT 80+ overall with no component below 21
- FPGEC Certificate: issued by NABP; fee $100 + documentation fees
- NAPLEX: USD 695 = ₹58,110
- 250 questions; 4.25 hours; Pearson VUE — USA only (not available in India)
- Topics: drug therapy knowledge, patient safety, medication dispensing
- Pass rate: ~85% for first-time US graduates; ~65–70% for internationally educated
- MPJE (pharmacy law): USD 335 = ₹28,010 — state-specific law exam
- Oregon, Montana, California: Historically more flexible with FPGEC requirements
- Note: All 50 states now require FPGEC for internationally trained pharmacists
- State licensing board fees: USD 150–600 additional per state
- US PharmD top-up (2-year programme if BPharm India) — STEM-designated programmes
- OR residency programme after PharmD
- OR employer-sponsored H-1B (Pharmacist is H-1B eligible; specialty occupation)
- Pharmacy (PharmD, CIP 51.2001): STEM-designated — 3-year STEM OPT for F-1 students
- Pharmaceutical Sciences (CIP 51.2010): STEM
- US pharmacy residency (PGY1/PGY2): not OPT-based; programme-arranged training
- Community Pharmacist (chain/retail): USD 105,000–135,000 (≈₹87.8–1,12.9 lakh)
- Hospital Clinical Pharmacist: USD 110,000–150,000 (≈₹92.0–1,25.4 lakh)
- Specialty Pharmacist (oncology, ID, critical care): USD 130,000–175,000 (≈₹1,08.7–1,46.4 lakh)
- Director of Pharmacy: USD 140,000–220,000 (≈₹1,17.0–1,84.0 lakh)
- Industry (pharma company): USD 90,000–160,000 (≈₹75.3–1,33.8 lakh)
- UAE, Saudi Arabia, Kuwait, Qatar, Bahrain: Indian pharmacists actively recruited
- UAE DHA (Dubai Health Authority) and HAAD (Abu Dhabi) licensure: exam-based (Prometric MCQ)
- UAE Pharmacist salary: AED 7,000–18,000/mo (≈₹1,58,000–4,07,000/mo tax-free) = ₹19–48.8 lakh/yr
- Saudi Arabia: SAR 7,000–16,000/mo (≈₹1,54,000–3,52,000/mo tax-free) = ₹18.5–42.2 lakh/yr
- UAE DHA Pharmacist exam: USD 220 = ₹18,400 — available at Prometric UAE; some Indian pharmacists sit in India at select Prometric centres
Indian Pharmacy Qualifications and Recognition Strategy
Indian Pharmacy Degrees — International Recognition:
- Recognised in Australia (APC document assessment required), UK (OSPAP likely needed), Canada (PEBC EE required), UAE (DHA/HAAD exam)
- Not directly recognised for US licensure (need FPGEC + NAPLEX pathway or top-up PharmD)
- Best international pathway: Australia (4-yr BPharm → APC → AHPRA → 189 PR)
- Higher international recognition than BPharm
- APC Australia: often substantially equivalent assessment (less bridging required)
- GPhC UK: may qualify for direct assessment without OSPAP (reforms ongoing 2026)
- PEBC Canada: better standing at EE stage
- FPGEC USA: PharmD meets educational requirements
- Most cost-effective future investment: Indian students currently in BPharm considering international careers should seriously consider completing PharmD as the 2 additional years significantly reduce bridging requirements globally
PCI (Pharmacy Council of India) Approval:
Your BPharm/PharmD institution must be PCI-approved. Verify at pci.nic.in — this is the first check international registration bodies perform.
Country Comparison Table:
- Australia after tax: AUD 55,000 → AUD 45,000 net (≈₹25.5 lakh take-home)
- UK after tax: £40,000 → £31,500 net (≈₹33.6 lakh take-home)
- Canada after tax: CAD 70,000 → CAD 50,000 net (≈₹30.4 lakh take-home)
- USA after tax: USD 120,000 → USD 85,000 net (≈₹71.1 lakh take-home)
- UAE after tax: AED 12,000/mo → AED 12,000/mo net (₹32.6 lakh — no tax)
Key Tip for Indian Pharmacists:
Pharmacists wanting fastest PR: Australia 189 via MLTSSL is the clearest route — APC assessment → AHPRA → 189 application, achievable in 2–3 years. Pharmacists wanting highest earning: USA, but H-1B lottery and NAPLEX USA-based sitting make it the hardest route. For tax-efficiency short-medium term: UAE — accumulate 3–5 years savings, then transition to Australia or Canada PR.
Frequently Asked Questions
Free Download · 2026/2027 Edition
UK Student Visa & IELTS Waiver Checklist
43-point checklist used by 2,000+ AnyUni students — CAS letter, finances, TB test, biometrics and IELTS waiver eligibility in one PDF.
Related Reading
Make Your Decision
Free tools and guides — no consultation needed
Ready to Start Your Application?
Get matched with universities that fit your profile — free of charge.
Compare pharmacy registration pathways and salary outcomes for Indian BPharm and PharmD graduates across Australia, UK, Canada, and USA on AnyUni.